LoneStar Heart Completes $20m Funding Led by Themes Investment Partners
Laguna Hills, Calif-based LoneStar Heart has completed a $20 million financing to support the clinical testing and regulatory clearance of its lead product, Algisyl-LVR. Hong Kong-based private equity fund Themes Investment Partners led the round. The new financing brings total funding in the company up to $35 million.
10 October 2012•3 mins read
